Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Lorazepam [USAN:USP:INN:BAN:JAN]
RN: 846-49-1
UNII: O26FZP769L
InChIKey: DIWRORZWFLOCLC-UHFFFAOYSA-N

Note

  • A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Molecular Formula

  • C15-H10-Cl2-N2-O2

Molecular Weight

  • 321.162
 

Classification Codes

Classification Codes

  • Anti-Anxiety Agents
  • Anticonvulsants
  • Antiemetics
  • Autonomic Agents
  • Central Nervous System Agents
  • Central Nervous System Depressants
  • Drug / Therapeutic Agent
  • GABA Agents
  • GABA Modulators
  • Gastrointestinal Agents
  • Human Data
  • Hypnotics and Sedatives
  • Neurotransmitter Agents
  • Peripheral Nervous System Agents
  • Psychotropic Drugs
  • Reproductive Effect
  • Tranquilizer (Minor)
  • Tranquilizing Agents

Superlist Classification Code

  • DEA Schedule IV
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Lorazepam
  • Lorazepam [USAN:USP:INN:BAN:JAN]

MeSH Heading

  • Lorazepam

Synonyms

  • (+-)-7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
  • 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-, (+-)-
  • 5-25-02-00248 (Beilstein Handbook Reference)
  • 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
  • 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1H-1,4-benzodiazepin-2(3H)-one
  • 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
  • Almazine
  • Anxiedin
  • Anxira
  • Anzepam
  • Aplacasse
  • Aplacassee
  • Apo-Lorazepam
  • Aripax
  • Ativan
  • Azurogen
  • Bonatranquan
  • Bonton
  • BRN 0759084
  • Delormetazepam
  • Demethyllormetazepam
  • Donix
  • Duralozam
  • Efasedan
  • EINECS 212-687-6
  • Emotion
  • Emotival
  • Equitam
  • Idalprem
  • Kalmalin
  • Larpose
  • Laubeel
  • Lomesta
  • Lopam
  • Lorabenz
  • Lorafen
  • Loram
  • Lorans
  • Lorapam
  • Lorat
  • Lorax
  • Loraz
  • Lorazene
  • Lorazep
  • Lorazepam
  • Lorazepam Fabra
  • Lorazepam Genericon
  • Lorazepam intensol
  • Lorazepam Lannacher
  • Lorazepam Medical
  • Lorazepam preservative free
  • Lorazepam-Efeka
  • Lorazepamum
  • Lorazepamum [INN-Latin]
  • Lorazepan Chobet
  • Lorazepan Richet
  • Lorazin
  • Lorazon
  • Lorenin
  • Loridem
  • Lorivan
  • Lorsedal
  • Lorzem
  • Lozepam
  • Max Pax
  • Merlit
  • Nervistop L
  • Nervistopl
  • NIC
  • Norlormetazepam
  • Novhepar
  • Novolorazem
  • NSC 289758
  • Nu Loraz
  • o-Chlorooxazepam
  • o-Chloroxazepam
  • Orfidal
  • Punktyl
  • Quait
  • Renaquil
  • Rocosgen
  • Sedatival
  • Sedizepan
  • Sidenar
  • Silence
  • Sinestron
  • Stapam
  • Tavor
  • Temesta
  • Titus
  • Tolid
  • Tranqipam
  • Trapax
  • UNII-O26FZP769L
  • Upan
  • Vigiten
  • WY 4036
  • Wy-4036
  • Wypax

Systematic Names

  • 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-
  • Lorazepam

Superlist Names

  • DEA No. 2885
  • Lorazepam

Registry Numbers

CAS Registry Number

  • 846-49-1

FDA UNII

  • O26FZP769L

System Generated Number

  • 0000846491

Structure Descriptors

InChI

InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)

InChIKey

DIWRORZWFLOCLC-UHFFFAOYSA-N

Smiles

OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 71ug/kg (0.071mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"		 Toxicology Letters. Vol. 2, Pg. 109, 1978.
child TDLo oral 1208ug/kg (1.208mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

LUNGS, THORAX, OR RESPIRATION: PLEURAL THICKENING		 Pediatric Emergency Care. Vol. 11, Pg. 32, 1995.
dog LD50 intramuscular > 25mg/kg (25mg/kg) BEHAVIORAL: ATAXIA

GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1065, 1971.
dog LD50 oral > 2gm/kg (2000mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: ATAXIA		 Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1065, 1971.
human TDLo oral 21ug/kg (0.021mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERATION OF CLASSICAL CONDITIONING		 Clinical Pharmacology and Therapeutics Vol. 39, Pg. 526, 1986.
human TDLo oral 28ug/kg (0.028mg/kg) BEHAVIORAL: CHANGES IN PSYCHOPHYSIOLOGICAL TESTS Journal of Clinical Psychiatry. Vol. 46, Pg. 137, 1985.
mouse LD50 intramuscular 70mg/kg (70mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1065, 1971.
mouse LD50 intraperitoneal 1810mg/kg (1810mg/kg)   Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 1, Pg. 5, 1974.
mouse LD50 oral 1850mg/kg (1850mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 8, Pg. 680, 1977.
mouse LD50 subcutaneous > 10gm/kg (10000mg/kg)   Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 1(1), Pg. 5, 1974.
rat LD50 intramuscular 59mg/kg (59mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1065, 1971.
rat LD50 intraperitoneal 870mg/kg (870mg/kg)   Pharmacology: International Journal of Experimental and Clinical Pharmacology. Vol. 10, Pg. 345, 1973.
rat LD50 oral 4500mg/kg (4500mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 8, Pg. 680, 1977.
rat LD50 subcutaneous > 10gm/kg (10000mg/kg)   Yakkyoku. Pharmacy. Vol. 28, Pg. 1475, 1977.
women TDLo oral 380ug/kg/19D- (0.38mg/kg) BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE

BLOOD: APLASTIC ANEMIA		 British Medical Journal. Vol. 296, Pg. 1332, 1988.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 167 deg C   EXP
pKa Dissociation Constant 13 (none)   EXP
log P (octanol-water) 2.39 (none)   EXP
Water Solubility 80 mg/L   EXP
Vapor Pressure 7.95E-13 mm Hg 25 EST
Henry's Law Constant 4.10E-10 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 1.12E-11 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.